![Richard Miller](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Miller
Vorstandsvorsitzender bei
CORVUS PHARMACEUTICALS, INC.
Vermögen: 29 Mio $ am 31.05.2026
Profil
Richard A. Miller was the founder of IDEC Pharmaceuticals Corp., founded in 1985, where the title held was Director & Vice President from 1985 to 2003.
Dr. Miller was the founder of Pharmacyclics LLC, founded in 1991, serving as President, Chief Executive Officer & Director from 1991 to 2008.
Dr. Miller was the founder of Principia Biopharma, Inc., founded in 2008, holding the titles of President, Chief Executive Officer & Director from 2009 to 2011.
Dr. Miller was the founder of Graphea, Inc., founded in 2012, where the titles were Chairman, President & Chief Executive Officer from 2012 to 2014.
Dr. Miller is the founder of Corvus Pharmaceuticals, Inc., founded in 2014, serving as Chairman, President & Chief Executive Officer since 2014.
Dr. Miller is the founder of Angel Pharmaceuticals Co., Ltd., founded in 2020, holding the titles Chairman & Chief Executive Officer since 2020.
Dr. Miller was also the founder of CellPro, Inc...
Dr. Miller was previously Director at BrainScope Co., Inc. since 2023.
Former positions include Independent Director at Bolt Biotherapeutics, Inc. from 2017 to 2024, Advisor at VantagePoint Management, Inc., and Chief Commercialization Officer & Associate Dean at The University of Texas at Austin from 2010 to 2011.
Education includes undergraduate studies at Franklin & Marshall College and a doctorate from The State University of New York, conferred in 1975.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 18.05.2026 | 2.331.742 ( 2,77 % ) | 29 Mio $ | 31.05.2026 |
Aktive Positionen von Richard Miller
| Unternehmen | Position | Beginn |
|---|---|---|
| CORVUS PHARMACEUTICALS, INC. | Vorstandsvorsitzender | 01.02.2014 |
Angel Pharmaceuticals Co., Ltd.
 Angel Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops medicines for treatment of cancer, autoimmune and infectious diseases | Vorstandsvorsitzender | 05.10.2020 |
BrainScope Co., Inc.
 BrainScope Co., Inc. Packaged SoftwareTechnology Services Operates as a medical neurotechnology company that develops AI-based, portable EEG platform solutions to objectively assess brain health at the point of care | Direktor/Vorstandsmitglied | 01.10.2023 |
Ehemalige bekannte Positionen von Richard Miller
| Unternehmen | Position | Ende |
|---|---|---|
| BOLT BIOTHERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 12.06.2024 |
Graphea, Inc.
 Graphea, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in physical, engineering & life sciences | Vorstandsvorsitzender | 01.10.2014 |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.12.2011 |
| PRINCIPIA BIOPHARMA INC. | Gründer | 01.02.2011 |
| PHARMACYCLICS, INC. | Gründer | 10.09.2008 |
Ausbildung von Richard Miller
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
62
Beziehungen ersten Grades
13
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
BrainScope Co., Inc.
BrainScope Co., Inc. Packaged SoftwareTechnology Services Operates as a medical neurotechnology company that develops AI-based, portable EEG platform solutions to objectively assess brain health at the point of care | Technology Services |
Principia Biopharma, Inc.
 Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a R&D driven and AI-powered biopharma company | Health Technology |
Corvus Pharmaceuticals, Inc.
 Corvus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides anticancer immuno-oncology drugs | Health Technology |
VantagePoint Management, Inc.
 VantagePoint Management, Inc. Investment ManagersFinance VantagePoint invests in companies located across the globe. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
IDEC Pharmaceuticals Corp.
 IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes targeted immunotherapies for the treatment of cancer and autoimmune diseases | Health Technology |
CellPro, Inc.
 CellPro, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
The University of Texas at Austin
The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Franklin & Marshall College
 Franklin & Marshall College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The State University of New York
 The State University of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Graphea, Inc.
Graphea, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in physical, engineering & life sciences | Commercial Services |
Bolt Biotherapeutics, Inc.
 Bolt Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company | Health Technology |
Angel Pharmaceuticals Co., Ltd.
Angel Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops medicines for treatment of cancer, autoimmune and infectious diseases | Health Technology |
